Acadia Healthcar Stock Price, News & Analysis

Acadia Healthcare Company (NASDAQ: ACHC) will participate in the Credit Suisse 31st Annual Healthcare Conference from November 7-10, 2022, at Terranea Resort, Rancho Palos Verdes, California. The company's presentation will be webcast live from their website on November 8, 2022, starting at 10:25 a.m. Pacific Time. A replay will be available for 30 days. Acadia operates 242 behavioral healthcare facilities with approximately 10,800 beds across 39 states and Puerto Rico, serving about 70,000 patients daily.

Acadia Healthcare Company (NASDAQ: ACHC) reported a 13.5% increase in revenue, totaling $666.7 million for Q3 2022, compared to the same quarter last year. Same-facility revenue rose 10.2%, driven by a 6.9% increase in revenue per patient day. Net income was $71.1 million ($0.78 per share), and adjusted EBITDA reached $162.8 million. The company opened new facilities, including a children's hospital in Chicago, and continues to expand its service offerings. Financial guidance for 2022 is narrowed, estimating revenue between $2.58 billion and $2.60 billion.

Acadia Healthcare Company (NASDAQ: ACHC) will release its Q3 2022 results on October 31, 2022, post-market. A conference call for institutional investors and analysts is scheduled for 9:00 a.m. ET on November 1, 2022. As of June 30, 2022, Acadia operates 239 facilities across the U.S. and Puerto Rico, providing services to approximately 70,000 patients daily. The company is the largest stand-alone behavioral health provider in the U.S., with over 22,500 employees and about 10,600 beds available.

On September 27, Acadia Healthcare and Henry Ford Health commenced construction on a new behavioral health facility in West Bloomfield, Michigan, expected to open in 2024. The hospital will span 120,000 square feet with an initial capacity of 184 inpatient beds, expandable to 192. This collaboration aims to address the surge in mental health needs exacerbated by the COVID-19 pandemic. The facility will also serve as an academic site, training future behavioral health providers.

Acadia Healthcare (NASDAQ: ACHC) has formalized an affiliation with Thomas Jefferson University in Philadelphia to enhance behavioral healthcare training and clinical care. This partnership will make Belmont Behavioral Health Hospital a primary teaching site for Jefferson's psychiatric residents and students. The collaboration aims to integrate behavioral and medical care, improve clinical outcomes, and develop new programs to meet the rising demand for behavioral healthcare services. Acadia operates 239 facilities across the U.S., serving around 70,000 patients daily.

Acadia Healthcare Company has appointed Dr. Nasser Khan, M.D., as the Operations Group President for its Comprehensive Treatment Center (CTC) business, effective September 6th. Dr. Khan will manage Acadia’s 145 CTC facilities, focusing on enhancing patient care amid the opioid crisis. He previously held senior roles at Shields Health Solutions and Biograph Inc. Dr. Khan aims to improve clinical outcomes and expand services to communities affected by addiction.

Acadia Healthcare (NASDAQ: ACHC) announced that select facilities will participate in a trial studying suicidal ideation and behavior in major depression, sponsored by Seelos Therapeutics (NASDAQ: SEEL) for the SLS-002 drug. This drug, an intranasal ketamine, aims to address an unmet need for treating these conditions. The trial includes a five-dose treatment regimen over 15 days. Acadia's involvement underscores its mission to deliver innovative care, with promising preliminary results for SLS-002.

Seelos Therapeutics (SEEL) has announced the participation of Acadia Healthcare (ACHC) in a registration-directed Proof of Concept study for SLS-002, intranasal racemic ketamine, targeting Acute Suicidal Ideation and Behavior (ASIB) in patients with Major Depressive Disorder (MDD). This collaborative effort seeks to evaluate the efficacy and safety of SLS-002 in patients at imminent risk of suicide. Acadia operates a well-established network of behavioral health facilities, treating thousands daily, enhancing the study's potential impact.